版本:
中国

BRIEF-Sensorion gets EU authorization to initiate phase II trial of SENS-111

March 9 Sensorion SA:

* Sensorion receives European authorization to initiate phase II clinical trial of SENS-111 to treat acute vertigo

* VHP enables Sensorion to conduct its phase II clinical trial in all European Union countries

* Protocol valid via voluntary harmonization procedure

* Patient enrollment is scheduled to begin during Q1 of 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐